A strain-based load identification model for beams in building structures.

Sensors (Basel)

Department of Architectural Engineering, Yonsei University, Seoul, Korea.

Published: August 2013

A strain-based load identification model for beam structures subjected to multiple loads is presented. The number of sensors for the load identification model is the same as the number of load conditions acting on a beam structure. In the model, the contribution of each load to the strains measured by strain sensors is defined. In this paper, the longitudinal strains measured from multiplexed fiber Bragg grating (FBG) strain sensors are used in the load identification. To avoid the dependency on the selection of locations for FBG sensors installed on a beam structure, the measured strain is expressed by a general form of a strain sensing model defined by superimposing the distribution shapes for strains from multiple loads. Numerical simulation is conducted to verify the model. Then, the load identification model is applied to monitoring of applied loads on a 4 m-long steel beam subjected to two concentrated loads. In the experiment, seven FBG sensors and nine electrical strain gages (ESGs) were installed on the surface of the bottom flange. The experimental results indicate a good agreement between estimated loadings from the model and the loads applied by a hydraulic jack.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812586PMC
http://dx.doi.org/10.3390/s130809909DOI Listing

Publication Analysis

Top Keywords

load identification
20
identification model
16
strain-based load
8
model
8
multiple loads
8
sensors load
8
beam structure
8
strains measured
8
measured strain
8
strain sensors
8

Similar Publications

Background: Patients with Alzheimer's Disease (AD) frequently manifest comorbid neuropsychiatric symptoms (NPS) with depression and anxiety being most prevalent. Previously we identified shared genetic risk loci between AD and major depressive disorder (MDD). In another study, we constructed a polygenic risk score (PRS) based on MDD-GWAS data and demonstrated its performance in predicting depression onset in LOAD patients.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

The Jackson Laboratory, Bar Harbor, ME, USA.

Background: Mechanisms driving cerebrovascular decline during Alzheimer's disease and related dementias (ADRD) are poorly understood. Methylenetetrahydrofolate reductase (MTHFR) is an enzyme in the folate/methionine pathway. Variants in MTHFR, notably 677C>T, are associated with ADRD.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Department of Neurology, Mayo Clinic, Rochester, MN, USA.

Background: Despite recent FDA approvement of disease-modifying treatments that reduce Aβ, the identification of novel therapeutic strategies that could delay the Alzheimer's disease (AD) development are needed. We identified and developed novel small molecule compounds that mildly inhibit mitochondrial complex I (MCI). Chronic treatment with a tool compound CP2 in 4 mouse models of familial AD was efficacious protecting against synaptic dysfunction and memory impairment, improving brain energetics and cognitive performance, reducing levels of human pTau and Ab.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA.

Background: Alzheimer's disease (AD) is a complex, multifactorial pathology with high heterogeneity in biological alterations. Our understanding of cellular and molecular mechanisms from disease risk variants to various phenotypes is still limited. Mouse models of AD serve as indispensable platforms for comprehensively characterizing AD pathology, disease progression, and biological mechanisms.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Penn Alzheimer's Disease Research Center, University of Pennsylvania, Philadelphia, PA, USA.

Background: Mobile, valid and engaging cognitive assessments are essential for detecting and tracking change in research participants and patients at risk for Alzheimer's Disease and Related Dementias (ADRDs). This pilot study aims to determine the feasibility and generalizability of an at-home, app-based cognitive assessment, the mobile cognitive app performance platform (mCAPP), to detect cognitive changes associated with aging and preclinical AD.

Method: mCAPP includes three gamified tasks (Figure 1): (1) a "concentration" memory task that includes learning and matching hidden card pairs with increasing memory load, pattern separation features (lure vs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!